27.08.2014 • News

LyondellBasell to Build New PO/TBA Plant on US Gulf Coast

LyondellBasell has announced it will build a world-scale plant for 900 million lbs (408,0000 t/y) of propylene oxide (PO) and 2 billion lbs (about 907,000 t/y) of tertiary butyl alcohol (TBA) and its derivatives on the US Gulf Coast, taking advantage of cheap shale gas-derived feedstock.

Initial plans see the new facility going on stream in 2019.

The Netherlands-based company said it expects to sell PO in the global marketplace to meet growing demand for polyurethanes. TBA and its derivatives will be sold to meet the need for high octane gasoline blending components as well as for use in manufacturing synthetic rubber and lubricant additives.

"While we have not finalized the exact location of the plant, the abundant natural gas liquids associated with shale gas make the US Gulf Coast an advantaged feedstock region," said Pat Quarles, senior vice president of intermediates and derivatives.

"This project combines our leading proprietary PO/TBA technology with low cost feedstock and demonstrates our continued commitment to capturing maximum advantage of market opportunities," Quarles added.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read